Terms: = Prostate cancer AND HOXD13, SPD, 3239, P35453, HOX4I
23 results:
1. Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse prostate (TRAMP) Model.
Ganguly K; Kishore U; Metkari SM; Madan T
Front Immunol; 2022; 13():930449. PubMed ID: 35874783
[TBL] [Abstract] [Full Text] [Related]
2. Rescuing cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear spd-L1 for immunotherapy.
Davidson TM; Foster N; Lucien F; Markovic S; Dong H; Winters JL; Park SS; Orme JJ
BMJ Open; 2022 May; 12(5):e050112. PubMed ID: 35551087
[TBL] [Abstract] [Full Text] [Related]
3. Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.
Shenderov E; Boudadi K; Fu W; Wang H; Sullivan R; Jordan A; Dowling D; Harb R; Schonhoft J; Jendrisak A; Carducci MA; Eisenberger MA; Eshleman JR; Luo J; Drake CG; Pardoll DM; Antonarakis ES
Prostate; 2021 May; 81(6):326-338. PubMed ID: 33636027
[TBL] [Abstract] [Full Text] [Related]
4. Membrane Interactome of a Recombinant Fragment of Human Surfactant Protein D Reveals GRP78 as a Novel Binding Partner in PC3, a Metastatic prostate cancer Cell Line.
Thakur G; Sathe G; Kundu I; Biswas B; Gautam P; Alkahtani S; Idicula-Thomas S; Sirdeshmukh R; Kishore U; Madan T
Front Immunol; 2020; 11():600660. PubMed ID: 33542717
[TBL] [Abstract] [Full Text] [Related]
5. hoxd13 suppresses prostate cancer metastasis and BMP4-induced epithelial-mesenchymal transition by inhibiting SMAD1.
Xu F; Shangguan X; Pan J; Yue Z; Shen K; Ji Y; Zhang W; Zhu Y; Sha J; Wang Y; Fan L; Dong B; Wang Q; Xue W
Int J Cancer; 2021 Jun; 148(12):3060-3070. PubMed ID: 33521930
[TBL] [Abstract] [Full Text] [Related]
6. The comparison of the survival outcome between robotic-assisted radical prostatectomy and radiation therapy for localized prostate cancer in men over 70 years: Korean Nationwide Observational Study.
Ko YH
J Robot Surg; 2021 Aug; 15(4):585-592. PubMed ID: 32918235
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma.
Soydal C; Nak D; Araz M; Akkus P; Urun Y; Ozkan E; Kucuk NO; Kir MK
Nucl Med Commun; 2019 Dec; 40(12):1243-1249. PubMed ID: 31688499
[TBL] [Abstract] [Full Text] [Related]
8. Time-resolved in vivo dosimetry for source tracking in brachytherapy.
Johansen JG; Rylander S; Buus S; Bentzen L; Hokland SB; Søndergaard CS; With AKM; Kertzscher G; Tanderup K
Brachytherapy; 2018; 17(1):122-132. PubMed ID: 28943129
[TBL] [Abstract] [Full Text] [Related]
9. Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Chen H; Na R; Packiam VT; Conran CA; Jiang D; Tao S; Yu H; Lin X; Meng W; Zheng SL; Brendler CB; Helfand BT; Xu J
Prostate; 2017 Aug; 77(11):1179-1186. PubMed ID: 28670847
[TBL] [Abstract] [Full Text] [Related]
10. Geographical miss of the prostate during image-guided radiotherapy with a 6-mm posterior expansion margin.
Oates R; Jones D; Foroudi F; Gill S; Ramachandran P; Schneider M; Lim Joon M; Kron T
J Med Radiat Sci; 2017 Jun; 64(2):97-105. PubMed ID: 27860454
[TBL] [Abstract] [Full Text] [Related]
11. Urinary Polyamines: A Pilot Study on Their Roles as prostate cancer Detection Biomarkers.
Tsoi TH; Chan CF; Chan WL; Chiu KF; Wong WT; Ng CF; Wong KL
PLoS One; 2016; 11(9):e0162217. PubMed ID: 27598335
[TBL] [Abstract] [Full Text] [Related]
12. Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.
Hyvönen MT; Ucal S; Pasanen M; Peräniemi S; Weisell J; Khomutov M; Khomutov AR; Vepsäläinen J; Alhonen L; Keinänen TA
Biochem J; 2016 May; 473(10):1433-41. PubMed ID: 27001865
[TBL] [Abstract] [Full Text] [Related]
13. Expression and Localization of Lung Surfactant Proteins in Human Testis.
Beileke S; Claassen H; Wagner W; Matthies C; Ruf C; Hartmann A; Garreis F; Paulsen F; Schicht M; Bräuer L
PLoS One; 2015; 10(11):e0143058. PubMed ID: 26599233
[TBL] [Abstract] [Full Text] [Related]
14. SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.
Toropainen S; Malinen M; Kaikkonen S; Rytinki M; Jääskeläinen T; Sahu B; Jänne OA; Palvimo JJ
Nucleic Acids Res; 2015 Jan; 43(2):848-61. PubMed ID: 25552417
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of free, mono- and diacetylated polyamines from human urine by LC-MS/MS.
Häkkinen MR; Roine A; Auriola S; Tuokko A; Veskimäe E; Keinänen TA; Lehtimäki T; Oksala N; Vepsäläinen J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():81-9. PubMed ID: 24185098
[TBL] [Abstract] [Full Text] [Related]
16. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
[TBL] [Abstract] [Full Text] [Related]
17. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract] [Full Text] [Related]
18. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.
Shiels MS; Chaturvedi AK; Katki HA; Gochuico BR; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2262-72. PubMed ID: 21828236
[TBL] [Abstract] [Full Text] [Related]
19. Discovering biological progression underlying microarray samples.
Qiu P; Gentles AJ; Plevritis SK
PLoS Comput Biol; 2011 Apr; 7(4):e1001123. PubMed ID: 21533210
[TBL] [Abstract] [Full Text] [Related]
20. Histrelin Hydrogel Implant--Valera: Histrelin implant, LHRH-Hydrogel implant, RL 0903, spd 424.
Drugs R D; 2005; 6(1):53-5. PubMed ID: 15801868
[TBL] [Abstract] [Full Text] [Related]
[Next]
